Abstract: A combined oropharyngeal airway/bite block is disclosed having pulse oximeter sensor elements capable of monitoring the posterior pharynx, the soft palate, the hard palate, and the buccal surface. The oropharyngeal airway portion has a thickened wall to house the pulse oximeter sensor elements and provide sufficient material to form grooves in the distal end. The grooves are utilized when the invention is turned on its side to act as a bite block with the grooves engaging the teeth of the patient. The pulse oximeter sensor elements include a light source, which emits light at wavelengths of about 660 nm and about 940 nm, and a light detector. The pulse oximeter sensor elements are in communication with a spectrophotometer for analysis.
Type:
Grant
Filed:
September 3, 1999
Date of Patent:
July 3, 2001
Assignee:
The United States of America as represented by the Secretary
of the Army
Inventors:
Steven C. Walker, John M. Shepherd, John G. Alexander
Abstract: An inactivated dengue virus vaccine to immunize and protect humans against dengue fever is described. The vaccine is based on dengue viruses which have been propagated to high titers in suitable cells, purified and inactivated under conditions which destroy infectivity but preserve immunogenicity, a high level of which is demonstrated in animal models.
Type:
Grant
Filed:
April 17, 1995
Date of Patent:
July 3, 2001
Assignee:
The United States of America as represented by the Secretary
of the Army
Inventors:
J. Robert Putnak, Kenneth Eckels, Doris R. Dubois
Abstract: This invention is a protective covering to protect off-the-shelf disposable pulse oximeter sensors from bodily or surgical fluids. The protective covering will envelop and encase the inserted pulse oximeter sensor up to a point on the connection cable extending from the pulse oximeter sensor. The protective covering is a polypropylene, rubber, or similar material, which preferably is tapered from the large width at the entrance to the narrower width at the blind end. The protective covering is bilaminar in nature to contain a substantially rectangular pulse oximeter.
Type:
Grant
Filed:
September 3, 1999
Date of Patent:
June 26, 2001
Assignee:
The United States of America as represented by the Secretary
of the Army
Abstract: Invaplex, a novel composition comprising invasin proteins and LPS from gram-negative bacteria is described as well as methods of using the novel composition as an adjuvant and a diagnostic tool.
Type:
Grant
Filed:
September 29, 1999
Date of Patent:
June 12, 2001
Assignee:
The United States of America as represented by the Secretary
of the Army
Abstract: A system and a method for providing a determination of predicted cognitive performance of an individual based the time of day and on factors including sleep history based on activity data from an actigraph. The system and the method provide a numerical representation of the predicted cognitive performance. Both may be used to optimize the work schedule of the actigraph wearer to maximize the cognitive capacity during working hours.
Type:
Grant
Filed:
September 3, 1999
Date of Patent:
June 5, 2001
Assignee:
The United States of America as represented by the Secretary
of the Army
Inventors:
Thomas J. Balkin, Gregory L. Belenky, Stanley W. Hall, Gary H. Kamimori, Daniel P. Redmond, Helen C. Sing, Maria L. Thomas, David R. Thorne, Nancy Jo Wesensten
Abstract: A controlled release microcapsule pharmaceutical formulation for burst-free, sustained, programmable release of a non-steroidal, antiinflammatory drug over a duration from 24 hours to 2 months, comprising: a non-steroidal, antiinflammatory drug and a blend of biocompatible, biodegradable poly (lactide/glycolide).
Type:
Grant
Filed:
July 5, 1996
Date of Patent:
April 17, 2001
Assignee:
The United States of America as represented by the Secretary
of the Army
Inventors:
William M. Vaugn, John E. Van Hamont, Jean A. Setterstrom
Abstract: An inactivated dengue virus vaccine to immunize and protect humans against dengue fever is described. The vaccine is based on dengue viruses which have been propagated to high titers in suitable cells, purified and inactivated under conditions which destroy infectivity but preserve immunogenicity, a high level of which is demonstrated in animal models. Uses of the inactivated dengue virus for detecting antibodies to dengue and kits therefor are also described.
Type:
Grant
Filed:
April 17, 1995
Date of Patent:
February 20, 2001
Assignee:
The United States of America as represented by the Secretary
of the Army
Inventors:
J. Robert Putnak, Kenneth Eckels, Doria R. Dubois, Kevin Cassidy
Abstract: Provided is a breeding container which is adapted to be lethal to container breeding mosquitoes which contains:
a walled structure defining an internal volume, the walled structure being constructed and arranged to contain an aqueous liquid within at least a portion of the internal volume;
at least one opening in the walled structure disposed so as to allow mosquitoes to enter the walled structure;
mosquito egg laying structure in the internal volume constructed and arranged such that female mosquitoes contact a surface of the mosquito egg laying structure; and
an insecticide that is lethal to mosquitoes present in an amount sufficient to kill the female mosquitoes in contact with the surface. Also provided is a lethal mosquito breeding container kit and a method for controlling the population of container breeding mosquitoes.
Type:
Grant
Filed:
September 7, 1999
Date of Patent:
February 13, 2001
Assignee:
The United States of America as represented by the Secretary
of the Army
Abstract: Compositions containing 2-(phosphonomethyl)-pentanedioic acid (PMPA) and pha. and .beta. N-acetyl-aspartyl-glutamate (NAAG) are appropriate means for treatment of neuronal tissue injury that may result from such factors as injury, toxicity, hypoxia or ischemia (a frequent cause of hypoxia). Target tissues include the brain, spinal cord and retina.
Type:
Grant
Filed:
August 13, 1998
Date of Patent:
December 12, 2000
Assignee:
The United States of America as represented by the Secretary of the Army
Inventors:
James M. Meyerhoff, Henry D. Hacker, Joseph B. Long
Abstract: Novel additive solutions useful for the storage of human red blood cells (RBCs) under refrigerated conditions are disclosed. Also disclosed is a method of using the additive solutions in an appropriate volume to preserve RBCs at about 1 to 6.degree. C. for up to 10 weeks. Additive solutions and processes in accordance with the present invention allow the viable storage of human RBCs for an extended period of time in a solution which is directly infusible in humans.
Type:
Grant
Filed:
September 16, 1998
Date of Patent:
November 21, 2000
Assignee:
The United States of America as represented by the Secretary of the Army
Abstract: A self-piercing pulse oximeter sensor is provided for attachment to subject, e.g., an individual or an animal. The device includes a flexible pulse oximeter sensor, an earring post, and a grommet. The earring post may be used as a piercing device if there is not a pierced body part suitable for attaching the pulse oximeter sensor to the body. Otherwise the earring post may be slid into the pierced hole. In either case, the tip of the earring post engages a grommet once passing through the body part. Thus, the pulse oximeter sensor functions in a transilluminance mode by transmitting light through the pierced body part.
Type:
Grant
Filed:
September 3, 1999
Date of Patent:
November 7, 2000
Assignee:
The United States of America as represented by the Secretary of the Army
Abstract: This invention relates to the discovery that toxicity to mustard may be euated by diagnostic test means disclosed herein. Upon electrophoretic separation (sodium dodocyl sulfate polyacryl-amide gel electrophoresis (SDS-PAGE)) of buffered extract of human skin cells (normal human epidermal keratinocytes (NHEK)) which had been exposed to mustard-type chemical compounds a band at approximately 50,000 to 80,000 daltons molecular weight was found. The protein band constitutes a biomarker. The marker protein can be used either to raise protective antibodies to protect against the protease or may be used in a kit for identifying presence or absence of the marker in study of tissues taken from individuals who may have been exposed to mustard poisoning.
Type:
Grant
Filed:
May 13, 1997
Date of Patent:
September 26, 2000
Assignee:
The United States of America as represented by the Secretary of the Army
Abstract: A recombinant protein encompassing a C-terminal protion from the structural envelope glycoprotein and an N-terminal portion from non-structural protein one of dengue type 2 virus was expressed in Escherichia coli as a fusion protein with Staphylococcal protein A. The recombinant protein was found to provide protection against lethal challenge with dengue 2 in mice.
Type:
Grant
Filed:
May 2, 1995
Date of Patent:
September 12, 2000
Assignee:
The United States of America as represented by the Secretary of the Army
Inventors:
Ashok Kumar Srivastava, J. Robert Putnak, Charles H. Hoke, Richard L. Warren
Abstract: An apparatus and method for measuring the true distance and relative velocity between first and second objects. The apparatus comprises a transceiver located at the first object which measures a first transit time for the transmission of a first signal from a first object to a second object and for the reflection of the first signal from the second object back to the first object. The transceiver further measures a second transit time for the transmission and reflection of a second signal, the second signal being transmitted immediately upon the reflection of the first signal back to the first object. First and second transit times can be used to calculate first and second apparent distances between the first and second objects, respectively. The apparatus also includes calculating means for determining the relative velocity between the first and second objects using the first transit time and the second transit time.
Abstract: Vaccines for the induction of immunity to malaria, based on aluminum hydroxide-treated, lipid A- and malarial antigen-containing liposomes, are described. Vaccines of this sort are useful in both humans and animals.
Type:
Grant
Filed:
February 27, 1995
Date of Patent:
July 25, 2000
Assignee:
The United States of America as represented by the Secretary of the Army
Abstract: This invention provides for recycling parasites and maintaining long-term cultures of P. vivax and P. ovale. Preferred conditions include 1) the immediate transfer of parasites to human reticulocytes during the first and second in vitro culture cycles, 2) the use of McCoy's 5A medium modified with L-glutamine containing 25 mM HEPES buffer supplemented with 20% human AB serum, 3) the continual addition of reticulocytes to the culture every 34-44 hours after the beginning of a new culture cycle, and 4) the use of alternate static (growth and differentiation phase) and shaker (invasion phase) culture.
Type:
Grant
Filed:
August 8, 1996
Date of Patent:
July 18, 2000
Assignee:
The United States of America as represented by the Secretary of the Army
Abstract: A recombinant protein encompassing the complete envelope glycoprotein and a portion of the carboxy-terminus of the membrane/premembrane protein of dengue 2 virus was expressed in baculovirus as a protein particle. The recombinant protein particle was purified and found to provide protection against lethal challenge with dengue 2 virus in mice.
Type:
Grant
Filed:
July 20, 1995
Date of Patent:
June 13, 2000
Assignee:
The United States of America as represented by the Secretary of the Army
Abstract: Sialic acids have the ability to prevent hyposialylation of cells as comptive inhibitors of endogenous sialidase. It is now also possible to develop antibodies to mammalian sialidase that significantly reduce influx of neutrophils into inflammatory sites.
Type:
Grant
Filed:
October 23, 1996
Date of Patent:
May 23, 2000
Assignee:
The United States of America as represented by the Secretary of the Army
Inventors:
Alan S. Cross, Nicholas Stamatos, Peter Gomatos